Abnormal motor phenotype at adult stages in mice lacking type 2 deiodinase

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Bárez López, Soledad ^a   Bosch García, Daniel ^a   Gómez Andrés, David ^b,c   Pulido Valdeolivas, Irene ^b,c   Montero Pedrazuela, Ana ^a   Obregon, Maria Jesus ^a   Guadaño Ferraz, Ana ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IODIDE PEROXIDASE; LIOTHYRONINE; THYROXINE; TYPE 1 DEIODINASE; TYPE 2 DEIODINASE; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CEREBELLUM; COAT HANGER TEST; COMPARATIVE STUDY; CONTROLLED STUDY; COORDINATION DISORDER; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; FALLING; FOOTPRINT TEST; FOUR LIMB HANGING TEST; GAIT; GASTROCNEMIUS MUSCLE; HISTOPATHOLOGY; KNOCKOUT MOUSE; LATENT PERIOD; LIOTHYRONINE BLOOD LEVEL; MOLECULAR DYNAMICS; MOTOR DYSFUNCTION; MOTOR SYSTEM; MOUSE; MUSCLE STRENGTH; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PREHENSILE REFLEX; PSYCHOMOTOR PERFORMANCE; REFLEX; ROTAROD TEST; SOLEUS MUSCLE; THYROXINE BLOOD LEVEL; VALIDATION PROCESS; WILD TYPE; ANIMAL; C57BL MOUSE; ENZYMOLOGY; GENETICS; LOCOMOTION; MALE; METABOLISM; PHYSIOLOGY; SKELETAL MUSCLE;

ANIMALS; CEREBRAL CORTEX; GAIT; IODIDE PEROXIDASE; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; THYROXINE; TRIIODOTHYRONINE;

EID: 84905457850     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103857     Document Type: Article

References (45)

1. Bernal J, Guadaño-Ferraz A, Morte B (2003) Perspectives in the study of thyroid hormone action on brain development and function. Thyroid 13: 1005-1012. (Pubitemid 37464553)
2. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, et al. (2008) Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 29: 898-938.
3. St Germain DL, Galton VA (1997) The deiodinase family of selenoproteins. Thyroid 7: 655-668. (Pubitemid 27371808)
4. Guadaño-Ferraz A, Obregon MJ, St Germain DL, Bernal J (1997) The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. Proc Natl Acad Sci U S A 94: 10391-10396. (Pubitemid 27407052)
5. Tu HM, Kim SW, Salvatore D, Bartha T, Legradi G, et al. (1997) Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 138: 3359-3368. (Pubitemid 27345689)
6. Guadaño-Ferraz A, Escamez MJ, Rausell E, Bernal J (1999) Expression of type 2 iodothyronine deiodinase in hypothyroid rat brain indicates an important role of thyroid hormone in the development of specific primary sensory systems. J Neurosci 19: 3430-3439. (Pubitemid 29203123)
7. Croteau W, Davey JC, Galton VA, St Germain DL (1996) Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest 98: 405-417. (Pubitemid 26255740)
8. Bates JM, St Germain DL, Galton VA (1999) Expression profiles of the three iodothyronine deiodinases, D1, D2, and D3, in the developing rat. Endocrinology 140: 844-851. (Pubitemid 29058221)
9. Salvatore D, Bartha T, Harney JW, Larsen PR (1996) Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology 137: 3308-3315. (Pubitemid 26250180)
10. Marsili A, Tang D, Harney JW, Singh P, Zavacki AM, et al. (2011) Type II iodothyronine deiodinase provides intracellular 3,5,3′-triiodothyronine to normal and regenerating mouse skeletal muscle. Am J Physiol Endocrinol Metab 301: E818-824.
11. Dentice M, Marsili A, Ambrosio R, Guardiola O, Sibilio A, et al. (2010) The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration. J Clin Invest 120: 4021-4030.
12. Marsili A, Ramadan W, Harney JW, Mulcahey M, Castroneves LA, et al. (2010) Type 2 iodothyronine deiodinase levels are higher in slow-twitch than fast-twitch mouse skeletal muscle and are increased in hypothyroidism. Endocrinology 151: 5952-5960.
13. Guo TW, Zhang FC, Yang MS, Gao XC, Bian L, et al. (2004) Positive association of the DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of China. J Med Genet 41: 585-590. (Pubitemid 39061263)
14. Zhang K, Xi H, Wang X, Guo Y, Huang S, et al. (2012) A family-based association study of DIO2 and children mental retardation in the Qinba region of China. J Hum Genet 57: 14-17.
15. He B, Li J, Wang G, Ju W, Lu Y, et al. (2009) Association of genetic polymorphisms in the type II deiodinase gene with bipolar disorder in a subset of Chinese population. Prog Neuropsychopharmacol Biol Psychiatry 33: 986-990.
16. Mentuccia D, Proietti-Pannunzi L, Tanner K, Bacci V, Pollin TI, et al. (2002) Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor. Diabetes 51: 880-883. (Pubitemid 34760206)
17. Canani LH, Capp C, Dora JM, Meyer EL, Wagner MS, et al. (2005) The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 90: 3472-3478. (Pubitemid 41014316)
18. Schneider MJ, Fiering SN, Pallud SE, Parlow AF, St Germain DL, et al. (2001) Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol 15: 2137-2148. (Pubitemid 33141133)
19. de Jesus LA, Carvalho SD, Ribeiro MO, Schneider M, Kim SW, et al. (2001) The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J Clin Invest 108: 1379-1385. (Pubitemid 33107766)
20. Ng L, Goodyear RJ, Woods CA, Schneider MJ, Diamond E, et al. (2004) Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase. Proc Natl Acad Sci U S A 101: 3474-3479. (Pubitemid 38338219)
21. Bassett JH, Boyde A, Howell PG, Bassett RH, Galliford TM, et al. (2010) Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts. Proc Natl Acad Sci U S A 107: 7604-7609.
22. Morreale de Escobar G, Obregon MJ, Escobar del Rey F (2004) Role of thyroid hormone during early brain development. Eur J Endocrinol 151 Suppl 3: U25-37. (Pubitemid 39627053)
23. Galton VA, Wood ET, St Germain EA, Withrow CA, Aldrich G, et al. (2007) Thyroid hormone homeostasis and action in the type 2 deiodinase-deficient rodent brain during development. Endocrinology 148: 3080-3088. (Pubitemid 46997018)
24. Wakeling EN, Fyfe JC (2011) Lix1 knockout mouse does not exhibit spinal muscular atrophy phenotype. J Hered 102 Suppl 1: S32-39.
25. Wei P, Blundon JA, Rong Y, Zakharenko SS, Morgan JI (2011) Impaired locomotor learning and altered cerebellar synaptic plasticity in pep-19/PCP4-null mice. Mol Cell Biol 31: 2838-2844.
26. Crawley J, editor (2000) What's Wrong With My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice. New York: Wiley-Liss.
27. Arqué G, de Lagran MM, Arbones ML, Dierssen M (2009) Age-associated motor and visuo-spatial learning phenotype in Dyrk1A heterozygous mutant mice. Neurobiol Dis 36: 312-319.
28. Venero C, Guadaño-Ferraz A, Herrero AI, Nordstrom K, Manzano J, et al. (2005) Anxiety, memory impairment, and locomotor dysfunction caused by a mutant thyroid hormone receptor alpha1 can be ameliorated by T3 treatment. Genes Dev 19: 2152-2163. (Pubitemid 41330317)
29. Burkholder TJ, Fingado B, Baron S, Lieber RL (1994) Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb. J Morphol 221: 177-190. (Pubitemid 2123416)
30. Morreale de Escobar G, Pastor R, Obregon MJ, Escobar del Rey F (1985) Effects of maternal hypothyroidism on the weight and thyroid hormone content of rat embryonic tissues, before and after onset of fetal thyroid function. Endocrinology 117: 1890-1900. (Pubitemid 16200779)
31. Obregon MJ, Ruiz de Oña C, Hernandez A, Calvo R, Escobar del Rey F, et al. (1989) Thyroid hormones and 59-deiodinase in rat brown adipose tissue during fetal life. Am J Physiol 257: E625-631.
32. Ruiz de Oña C, Morreale de Escobar G, Calvo R, Escobar del Rey F, Obregon MJ (1991) Thyroid hormones and 59-deiodinase in the rat fetus late in gestation: effects of maternal hypothyroidism. Endocrinology 128: 422-432.
33. Koibuchi N, Jingu H, Iwasaki T, Chin WW (2003) Current perspectives on the role of thyroid hormone in growth and development of cerebellum. Cerebellum 2: 279-289. (Pubitemid 38280285)
34. Marsili A, Aguayo-Mazzucato C, Chen T, Kumar A, Chung M, et al. (2011) Mice with a targeted deletion of the type 2 deiodinase are insulin resistant and susceptible to diet induced obesity. PLoS One 6: e20832.
35. Silva JE, Gordon MB, Crantz FR, Leonard JL, Larsen PR (1984) Qualitative and quantitative differences in the pathways of extrathyroidal triiodothyronine generation between euthyroid and hypothyroid rats. J Clin Invest 73: 898-907. (Pubitemid 14132817)
36. Leonard JL, Kaplan MM, Visser TJ, Silva JE, Larsen PR (1981) Cerebral cortex responds rapidly to thyroid hormones. Science 214: 571-573. (Pubitemid 12206157)
37. Klapdor K, Dulfer BG, Hammann A, Van der Staay FJ (1997) A low-cost method to analyse footprint patterns. J Neurosci Methods 75: 49-54. (Pubitemid 27314526)
38. Ruiz de Oña C, Obregon MJ, Escobar del Rey F, Morreale de Escobar G (1988) Developmental changes in rat brain 59-deiodinase and thyroid hormones during the fetal period: the effects of fetal hypothyroidism and maternal thyroid hormones. Pediatr Res 24: 588-594. (Pubitemid 18266168)
39. Grozovsky R, Ribich S, Rosene ML, Mulcahey MA, Huang SA, et al. (2009) Type 2 deiodinase expression is induced by peroxisomal proliferator-activated receptor-gamma agonists in skeletal myocytes. Endocrinology 150: 1976-1983.
40. Amendola E, De Luca P, Macchia PE, Terracciano D, Rosica A, et al. (2005) A mouse model demonstrates a multigenic origin of congenital hypothyroidism. Endocrinology 146: 5038-5047. (Pubitemid 41655945)
41. Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR (2005) Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest 115: 2524-2533. (Pubitemid 41266215)
42. Arrojo EDR, Fonseca TL, Werneck-de-Castro JP, Bianco AC (2013) Role of the type 2 iodothyronine deiodinase (D2) in the control of thyroid hormone signaling. Biochim Biophys Acta 1830: 3956-3964.
43. Dumitrescu AM, Refetoff S (2011) Inherited defects of thyroid hormone metabolism. Ann Endocrinol (Paris) 72: 95-98.
44. Christoffolete MA, Linardi CC, de Jesus L, Ebina KN, Carvalho SD, et al. (2004) Mice with targeted disruption of the Dio2 gene have cold-induced overexpression of the uncoupling protein 1 gene but fail to increase brown adipose tissue lipogenesis and adaptive thermogenesis. Diabetes 53: 577-584. (Pubitemid 38270625)
45. Castillo M, Hall JA, Correa-Medina M, Ueta C, Kang HW, et al. (2011) Disruption of thyroid hormone activation in type 2 deiodinase knockout mice causes obesity with glucose intolerance and liver steatosis only at thermoneutrality. Diabetes 60: 1082-1089.